Selected article for: "city lock and end point"
Author: Conghua Xie; Xiaoyong Wang; Hui Liu; Zhirong Bao; Jing Yu; Yahua Zhong; Melvin LK Chua
Title: Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan
  • Document date: 2020_3_24
    • ID: njo93g3h_4
    Snippet: We reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020 . This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcar.....
    Document: We reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020 . This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcare staff. Diagnosis of COVID-19 was based on the 5 th edition criteria. during the study period. No healthcare worker was infected.

    Search related documents:
    Co phrase search for related documents
    • clinical pathway and healthcare staff: 1, 2, 3
    • clinical pathway and healthcare staff patient: 1
    • clinical pathway and healthcare worker: 1
    • clinical pathway and infection control: 1, 2, 3, 4
    • clinical pathway and infection rate: 1, 2
    • clinical pathway and lock date: 1
    • clinical pathway and primary end point: 1
    • clinical pathway and RT facility: 1, 2
    • clinical pathway and site screening: 1, 2
    • clinical pathway and study period: 1, 2
    • end point and healthcare staff: 1
    • end point and healthcare worker: 1
    • end point and infection control: 1, 2, 3, 4
    • end point and infection rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • end point and lock date: 1
    • end point and primary end point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • end point and RT facility: 1
    • end point and site screening: 1
    • end point and study period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19